Innovation and excellence in science and health

Labs and offices

Labs and offices

Phase 2 – The land comprising Phase 1 of the commercial expansion of the Campus has now been allocated. Phase 2 comprises 20 acres located south of Dame Mary Archer Way which has been ring-fenced for future development.  An outline planning application for Phase 2 will be submitted in January 2016 with a view to accommodating up to 1m sq ft of new buildings.

Multi-occupier buildings

Accommodation will be available in multi-occupier buildings  for companies that require flexibility in terms of size of unit and length of lease. Plans and a detailed specification have been drafted for the 80- 100,000 sq ft multi-occupancy building pictured below comprising wet labs (chemistry and biology) and dry-labs as well as offices and clinics. Individual floors can be divided into smaller units depending on demand.

Bespoke buildings

For larger requirements, bespoke buildings can be designed to meet the unique needs of an individual occupier.  Companies have the option of buying their building outright or leasing it, either as a shell and core, or partly or fully-fitted out. The costs of fit-out can be rentalised to reduce initial capital outlay.

Contact us today

Whatever your requirements, large or small, short or long term, please talk to us today so we can factor your needs into our plans.  Our Project Director, Jeanette Walker (jeanette@cambridge-biomedical.com), is based at the marketing suite on the Biomedical Campus and would be pleased to discuss the benefits to your company in locating on the Campus.

Developers

Liberty Property Trust

Countryside

Liberty Property Trust and Countryside were appointed as the development partner for the Campus expansion in 2003 following a competitive tender led by Bidwells on behalf of the Hospital Trust, its partners and the landowners.  The two companies had worked together previously on commercial projects in the UK including the Chertsey regeneration project and the redevelopment of a former hospital in Didsbury in south Manchester into a mixed-use development which will include a new 75,000 sq ft private hospital for the Circle Health Group.

In 2009, Liberty and Countryside secured the release of the greenbelt land and  successfully obtained outline planning consent for the expanded site. They also played the lead role in attracting AstraZeneca to the Campus. Other milestone achievements include the sale of land to the Medical Research Council for its new 27,000 sq m building to house the Laboratory of Molecular Biology and the agreement with Papworth Hospital which will see the relocation of the hospital to the Campus in 2017.

To support the development, Liberty and Countryside have assembled a group  of experts with a broad range of skills and experience in commercial real estate and marketing. Click here to find out more about the team’s expertise.